376 related articles for article (PubMed ID: 15845519)
1. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
Andrade RM; Portillo JA; Wessendarp M; Subauste CS
Infect Immun; 2005 May; 73(5):3115-23. PubMed ID: 15845519
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
[TBL] [Abstract][Full Text] [Related]
3. CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon.
Subauste CS; Wessendarp M
Infect Immun; 2006 Mar; 74(3):1573-9. PubMed ID: 16495528
[TBL] [Abstract][Full Text] [Related]
4. Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling.
Zhao Y; Wilson D; Matthews S; Yap GS
Infect Immun; 2007 Oct; 75(10):4799-803. PubMed ID: 17682046
[TBL] [Abstract][Full Text] [Related]
5. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism.
Andrade RM; Wessendarp M; Subauste CS
J Immunol; 2003 Dec; 171(12):6750-6. PubMed ID: 14662879
[TBL] [Abstract][Full Text] [Related]
6. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
7. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
8. The CD40-autophagy pathway is needed for host protection despite IFN-Γ-dependent immunity and CD40 induces autophagy via control of P21 levels.
Portillo JA; Okenka G; Reed E; Subauste A; Van Grol J; Gentil K; Komatsu M; Tanaka K; Landreth G; Levine B; Subauste CS
PLoS One; 2010 Dec; 5(12):e14472. PubMed ID: 21217818
[TBL] [Abstract][Full Text] [Related]
9. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
Yap GS; Sher A
J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.
Langermans JA; Nibbering PH; Van Vuren-Van Der Hulst ME; Van Furth R
Parasite Immunol; 2001 Apr; 23(4):169-75. PubMed ID: 11298293
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
12. TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha.
Andrade RM; Wessendarp M; Portillo JA; Yang JQ; Gomez FJ; Durbin JE; Bishop GA; Subauste CS
J Immunol; 2005 Nov; 175(9):6014-21. PubMed ID: 16237096
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice.
Freund YR; Zaveri NT; Javitz HS
Infect Immun; 2001 Feb; 69(2):765-72. PubMed ID: 11159966
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the dose and the anti-Toxoplasma effect of activated mouse macrophages induced by IFN-gamma and the synergism between IFN-gamma and TNF-alpha].
Zhang A; Yang H; Yang Y; Qian Z
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(6):436-40. PubMed ID: 12078289
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1.
Mahmoud ME; Ui F; Salman D; Nishimura M; Nishikawa Y
Cell Microbiol; 2015 Jul; 17(7):1069-83. PubMed ID: 25628099
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
17. LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction.
Atochina O; Harn D
Clin Diagn Lab Immunol; 2005 Sep; 12(9):1041-9. PubMed ID: 16148169
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors.
Nishikawa Y; Kawase O; Vielemeyer O; Suzuki H; Joiner KA; Xuan X; Nagasawa H
Parasite Immunol; 2007 Jul; 29(7):375-85. PubMed ID: 17576367
[TBL] [Abstract][Full Text] [Related]
19. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.
Andrade RM; Wessendarp M; Gubbels MJ; Striepen B; Subauste CS
J Clin Invest; 2006 Sep; 116(9):2366-77. PubMed ID: 16955139
[TBL] [Abstract][Full Text] [Related]
20. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
Fehr T; Schoedon G; Odermatt B; Holtschke T; Schneemann M; Bachmann MF; Mak TW; Horak I; Zinkernagel RM
J Exp Med; 1997 Mar; 185(5):921-31. PubMed ID: 9120398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
